4. FORMULATION STRATEGY LOGIC (LIPOSOMAL GLUTATHIONE SYSTEM)

✔ Structure remains standardized for internal R&D consistency and regulatory traceability
✔ Content is customized based on glutathione stability science and target market positioning

We develop Liposomal Glutathione Supplements using multi-dimensional formulation logic based on:

• Regulatory alignment across target markets

Different regions (FDA / EFSA / NMPA / others) have distinct expectations regarding:

• Classification of reduced glutathione (GSH) as dietary antioxidant ingredient
• Permitted use levels in oral supplements and functional formulations
• Claims compliance related to “antioxidant support,” “cellular protection,” and “liver health support”
• Restrictions on therapeutic or detoxification claims

All formulations are designed to ensure claim-safe positioning under global supplement regulations.

• Bioavailability & liposomal delivery optimization

Glutathione has inherently low oral bioavailability due to enzymatic degradation in the digestive tract.

Therefore, formulation design focuses on:

• Liposomal encapsulation for gastrointestinal protection
• Phospholipid-based absorption enhancement (cell membrane mimicry)
• Intracellular delivery efficiency improvement
• Protection from first-pass metabolism breakdown

→ Core objective: maximize systemic availability of reduced glutathione

• Ingredient stability & oxidation control engineering

Glutathione (GSH) is highly sensitive to:

• Oxidation (conversion to GSSG form)
• Moisture and oxygen exposure
• Temperature stress during processing
• pH instability in liquid systems

We apply stabilization strategies such as:

• Liposomal shielding technology
• Nitrogen-protected manufacturing environments
• Antioxidant co-formulation systems (synergistic protection matrix)
• Low-temperature emulsification and blending systems

• Functional synergy & metabolic support design

To enhance systemic antioxidant efficiency, formulations may integrate:

• Endogenous glutathione recycling support pathways
• Cellular redox balance optimization (GSH/GSSG ratio support)
• Enzymatic cofactor support for glutathione peroxidase activity
• Complementary antioxidant network integration

• Commercial scalability & manufacturing feasibility

All formulations are designed to ensure:

• GMP-compliant scalable production
• Stable raw material sourcing chain (phospholipids + glutathione grades)
• Compatible dosage forms (capsule / liquid / sachet / softgel)
• Cost structure adaptability (premium / clinical / mass wellness positioning)

Available formulation strategies:

• Direct reduced glutathione system

Uses high-purity reduced L-glutathione (GSH) as active ingredient
→ Suitable for standard antioxidant support products

• Liposomal glutathione delivery system

Encapsulated glutathione within phospholipid liposomal carriers
→ Enhances absorption, stability, and cellular uptake efficiency
→ Core premium delivery format

• Synergistic antioxidant regeneration system

Combines glutathione with supporting antioxidant network:

• Vitamin C (ascorbate recycling system)
• Alpha-lipoic acid (redox cycling support)
• Selenium-dependent enzymatic cofactors
• NAC (precursor support for endogenous GSH synthesis)

→ Designed for high-performance antioxidant + cellular defense positioning

5. OPTIONAL INGREDIENT MODULES (LIPOSOMAL GLUTATHIONE SYSTEM)

This section defines optional functional modules that can be integrated based on product positioning, regulatory requirements, and target consumer needs.

Each Liposomal Glutathione formulation is built on a core antioxidant delivery system and can be extended using scientifically validated functional modules.

✔ Modules are selectively applied depending on:

• Target market regulations (FDA / EFSA / NMPA)
• Product positioning (clinical / premium wellness / beauty / detox support)
• Delivery format (capsule / liquid / sachet / softgel)
• Liposomal stability and compatibility constraints

• Glutathione Core System / Active Antioxidant Base

Primary functional foundation responsible for intracellular antioxidant defense:

• Reduced L-Glutathione (GSH)
• Liposomal delivery matrix (phospholipid-based)
• Enzymatic recycling support cofactors

• Antioxidant Network System

Designed to strengthen redox balance and glutathione recycling efficiency:

• Vitamin C (ascorbate regeneration loop)
• Alpha-lipoic acid (universal antioxidant recycler)
• Vitamin E lipid-phase protection system
• Polyphenol-based oxidative stress modulation

• Liver Detox & Phase II Support System

Supports glutathione’s primary biological pathway association (hepatic detoxification):

• Milk thistle extract (silymarin complex)
• NAC (glutathione precursor support)
• Sulfur amino acid complexes (methionine / cysteine support)
• Selenium-dependent detox enzymes support

• Bioavailability Enhancement System

Improves absorption efficiency and intracellular delivery:

• Advanced liposomal encapsulation system
• Phospholipid carrier matrix optimization
• Nano-emulsion stabilization technology
• Absorption-enhancing co-solvent systems

• Skin Brightening & Beauty Longevity System (Optional)

For beauty-from-within positioning:

• Melanin regulation antioxidant support
• Collagen protection via oxidative stress reduction
• Vitamin C + glutathione synergy system
• Skin cellular repair cofactors

• Immune Defense Support System (Optional)

For immune resilience positioning:

• Zinc and selenium immune cofactors
• Antioxidant-mediated immune cell protection
• Oxidative stress reduction for immune balance
• Vitamin D synergistic immune modulation support

• Mitochondrial Energy Support System (Optional)

For energy + vitality positioning:

• Coenzyme Q10 (ubiquinol form preferred)
• PQQ mitochondrial biogenesis support
• L-carnitine energy transport system
• ATP oxidative protection enhancement

• Adaptogen Stress Response System (Optional)

For stress resilience and recovery positioning:

• Rhodiola rosea standardized extracts
• Ashwagandha adaptogenic complexes
• Cortisol regulation support systems
• Neuro-oxidative stress reduction compounds

Implementation Rules (Important)

Not all modules are included in every formulation.

Each Liposomal Glutathione Formula is customized by:

• Selecting stability-compatible ingredient combinations
• Ensuring lipid-phase compatibility with liposomal system
• Removing non-relevant functional modules
• Maintaining full regulatory compliance per target market

6. REGULATORY & COMPLIANCE（Pre-Formulation Compliance Framework）

✔ This section follows a standardized structure to ensure global regulatory traceability and market entry feasibility assessment.

Regulatory strategy is integrated at the earliest stage of formulation development to minimize compliance risk, prevent reformulation delays, and ensure global market adaptability for liposomal antioxidant systems.

• United States (FDA Compliance Framework)

Formulation design considers:

• Dietary Supplement Health and Education Act (DSHEA) requirements
• New Dietary Ingredient (NDI) notification risk assessment (especially for novel liposomal systems or high-dose actives)
• GRAS (Generally Recognized As Safe) ingredient validation where applicable
• Supplement Facts labeling compliance and structure/function claim boundaries

✔ Early-stage ingredient screening is conducted to reduce NDI filing exposure and ensure DSHEA-compliant positioning.

• European Union (EFSA / Novel Food Regulation)

We evaluate:

• Novel Food classification under EU Regulation (EU) 2015/2283 (especially liposomal delivery systems)
• EFSA safety dossier requirements for antioxidants, phospholipids, and bioactive compounds
• Maximum permitted levels for vitamins, minerals, and functional antioxidants
• Health claim compliance under Regulation (EC) No 1924/2006

✔ Only EU-compliant or pre-assessable ingredients are advanced into liposomal formulations targeting European markets.

• Canada (Natural Health Products – NHP Framework)

Compliance review includes:

• NPN (Natural Product Number) licensing feasibility
• Health Canada monograph alignment (where applicable, e.g., antioxidants, glutathione-related compounds)
• Classification of medicinal vs non-medicinal ingredients
• Dosage form compliance and labeling requirements for NHP registration

• Other International Markets (UK / Australia / Asia / Middle East)

Regulatory review is conducted case-by-case, including:

• UK MHRA supplement and post-Brexit regulatory alignment
• TGA (Australia) listed vs registered medicine classification
• ASEAN supplement harmonization guidelines
• GCC / Middle East import and labeling compliance requirements

• Pre-Formulation Regulatory Risk Assessment (Critical Step)

Before finalizing any Liposomal Glutathione formulation, we perform structured compliance screening:

• Global ingredient regulatory status mapping (multi-country database screening)
• Claim limitation analysis (antioxidant / detox / cellular protection positioning)
• Liposomal delivery system classification risk evaluation (novel excipient assessment)
• Export documentation readiness check (COA, specs, stability, labeling)

✔ Ensures each formulation is scientifically valid, legally compliant, and commercially approvable across target markets.

7. QUALITY CONTROL SYSTEM（Fully Integrated GMP Quality Assurance System）

✔ This system is standardized across all formulations to ensure batch consistency, regulatory compliance, and global traceability.

Our QC framework is embedded across the entire lifecycle—from raw material verification to finished liposomal product release.

Certifications: cGMP, ISO 22000, HACCP, FSSC 22000, Kosher, Halal, FDA Registered.

• Raw Material Identity Verification

Each raw material is validated using advanced analytical methods:

• HPLC (High-Performance Liquid Chromatography)
• FTIR (Fourier Transform Infrared Spectroscopy)
• Phospholipid profile verification (for liposomal carriers)
• Reference standard matching against approved specifications

✔ Ensures only authenticated glutathione and lipid carriers enter production.

• Contaminant Safety Assurance

Safety testing follows USP and ICH global standards:

• Heavy metals (Pb, As, Cd, Hg)
• Microbiological contamination (pathogens & total count)
• Pesticide residues (botanical co-ingredients if applicable)
• Residual solvent screening (liposomal processing inputs)

✔ Ensures global safety threshold compliance.

• Product Stability Validation

Liposomal systems undergo enhanced stability evaluation:

• Accelerated stability testing (temperature + humidity stress)
• Liposome integrity monitoring (particle size distribution / encapsulation efficiency)
• Long-term oxidative stability tracking (GSH/GSSG ratio retention)
• Physical, chemical, and microbiological stability assessment

✔ Ensures liposomal structure and glutathione potency remain stable across shelf life.

• Batch Traceability & Retention System

Each batch is fully traceable via digital QA system:

• Unique batch coding system
• Retained reference samples for regulatory audits
• Full production and QC documentation archive

✔ Enables full backward traceability from finished product to raw phospholipid and active ingredient sources.

• Certificate of Analysis (COA) Documentation

Each batch is released with a complete COA package:

• Active ingredient assay (Glutathione content verification)
• Encapsulation efficiency (liposomal system validation where applicable)
• Contaminant and safety test reports
• Stability confirmation summary (if required by market)
• Batch manufacturing record summary

✔ COA is standard for all international shipments.

8. PRODUCTION CAPABILITY（Scalable GMP Manufacturing System）

✔ This section defines validated manufacturing capability from pilot development to full-scale commercial liposomal production.

Our system ensures high encapsulation efficiency, oxidative protection, and scalable output consistency.

• Multi-Form Dosage Manufacturing Capability

We support multiple delivery formats:

• Liposomal liquid systems (oral emulsions / concentrates)
• Capsule systems (liposomal powder-filled capsules)
• Sachet powder systems (instant mix formulations)
• Softgel encapsulated antioxidant systems

✔ All production is conducted under GMP-controlled environments optimized for lipid-based systems.

• Pilot-to-Commercial Scale Transition System

We provide full lifecycle manufacturing support:

• Lab-scale liposomal system validation
• Pilot batch optimization (encapsulation efficiency + stability)
• Industrial-scale production transfer

✔ Ensures scale-up without loss of liposomal integrity or glutathione activity.

• Process Consistency & Batch Control

Strict process control ensures reproducibility:

• High-shear emulsification standardization
• Controlled phospholipid hydration process
• Particle size distribution control systems
• In-process encapsulation efficiency monitoring

✔ Batch variability controlled with RSD ≤ 5% for key active parameters.

• Industrial-Scale GMP Manufacturing Capacity

Designed for global supply chain requirements:

• Multiple liposomal production lines
• Dedicated emulsification and filling systems
• Flexible capacity allocation for different markets

✔ Supports both premium niche brands and large-scale global distribution.

• Quality-Integrated Manufacturing Execution

Production is fully integrated with QC systems:

• In-process testing at critical control points
• Real-time monitoring of liposomal stability parameters
• Final release only after full QA approval

✔ Ensures pharmaceutical-grade consistency for nutraceutical products.

9. MOQ & SCALING MODEL（Phased Manufacturing & Market Scaling Framework）

✔ Structured scaling model designed to reduce market entry risk and ensure stable commercial expansion.

• Pilot Batch (Technical Validation Stage)

500–1,000 units

• Liposomal stability verification
• Absorption and formulation validation
• Early-stage market feedback testing

✔ Purpose: de-risk formulation before commercial investment.

• First Commercial Batch (Market Entry Stage)

5,000–10,000 units

• Initial market launch production
• Channel and consumer validation
• Packaging and positioning optimization

✔ Purpose: bridge validation and scalable commercialization.

• Full-Scale Production (Market Expansion Stage)

100,000+ units per batch

• High-volume GMP manufacturing
• Optimized cost structure
• Stable global supply chain execution

✔ Purpose: support long-term brand scaling.

• Flexible Scaling Strategy

Scaling is dynamically adjusted based on:

• Market performance data
• Regional regulatory clearance status
• Raw material availability (phospholipids + glutathione)
• Channel expansion requirements

✔ Enables smooth transition from niche antioxidant brand to global distribution.

10. PROJECT TIMELINE（Standardized Product Development Cycle）

✔ Structured timeline ensures predictable execution from concept to commercialization.

• Requirement Confirmation & Technical Alignment

3–5 days

• Market positioning definition
• Liposomal system feasibility review
• Regulatory pre-screening

✔ Output: validated formulation roadmap

• Sample Development & Lab Optimization

7–14 days

• Prototype liposomal formulation
• Encapsulation efficiency adjustment
• Functional performance testing

✔ Output: evaluation-ready samples

• Stability Pre-Testing Phase

2–4 weeks

• Accelerated stability evaluation
• Liposomal integrity monitoring
• Oxidative stability assessment

✔ Output: preliminary stability report

• Pilot Production & Process Validation

1–2 weeks

• GMP pilot batch manufacturing
• Process parameter optimization
• Batch reproducibility verification

✔ Output: validated pilot batch

• Full-Scale Commercial Production

2–4 weeks

• Industrial manufacturing
• Full QC release testing
• Packaging finalization

✔ Output: market-ready production batches

Total Project Timeline

6–10 weeks
(depending on liposomal complexity, regulatory pathway, and ingredient availability)

11. SUPPLY CHAIN SECURITY（Controlled Raw Material Assurance System）

✔ This section defines our structured supply chain risk management system to ensure raw material continuity, traceability, and regulatory compliance across global liposomal manufacturing operations.

Our sourcing system is specifically designed to maintain phospholipid system stability, reduced glutathione integrity, and uninterrupted GMP production continuity.

• Dual Sourcing Strategy for Key Raw Materials

Critical raw materials are secured through a validated dual-supplier system:

• Primary and secondary qualified suppliers for:
  • Reduced L-Glutathione (GSH)
  • Phospholipid/liposomal carrier systems
  • Stabilization co-antioxidants (ascorbate / ALA systems)
• Cross-validation of raw material specifications and assay consistency
• Geographic diversification to reduce geopolitical and logistics risk exposure

✔ Ensures uninterrupted production even under global supply chain volatility.

• Approved Vendor List (AVL) Management System

All suppliers operate under a strictly controlled Approved Vendor List (AVL):

• Pre-qualification audits (quality system + GMP compliance verification)
• Raw material specification alignment validation
• Ongoing supplier performance scoring (quality / delivery / consistency)
• Periodic re-audit and compliance re-certification

✔ Only fully qualified and continuously monitored suppliers are permitted in production.

• Batch-Level COA Verification System

Each raw material batch undergoes dual-layer verification:

• Supplier Certificate of Analysis (COA) review
• Internal laboratory validation testing
• Identity confirmation (HPLC / FTIR where applicable)
• Purity and degradation marker screening (critical for glutathione oxidation control)

✔ Any deviation triggers automatic batch rejection protocol.

• Strategic Safety Stock Management

We maintain structured inventory buffering for key inputs:

• 3–6 months safety stock for critical actives and phospholipids
• Demand forecasting integrated procurement system
• Emergency replenishment protocol for high-volume SKUs
• Priority allocation system for long-term clients

✔ Prevents production delays and ensures stable global supply continuity.

• Controlled Upstream Integration (Selected Raw Materials)

For selected botanical and functional raw materials, we maintain controlled upstream sourcing systems:

• Standardized botanical extract supply partnerships
• Controlled lipid/phospholipid sourcing channels for liposomal systems
• Traceable raw material origin documentation (batch-to-farm level where applicable)
• Qualified agricultural or fermentation-based ingredient systems under GMP-aligned standards

✔ Ensures traceability, cost stability, and raw material authenticity.

12. IP & CONFIDENTIALITY（Intellectual Property Protection Framework）

✔ This section defines the legal and operational framework for protecting client formulations, ensuring confidentiality, exclusivity, and full ownership rights in OEM/ODM collaboration.

Our model is structured to guarantee zero formulation leakage risk and full brand asset protection.

• Non-Disclosure Agreement (NDA) – Pre-Development Requirement

A legally binding NDA is available prior to any technical exchange, covering:

• Liposomal formulation architecture and delivery systems
• Ingredient strategy and antioxidant synergy design
• Market positioning and commercialization roadmap
• Supplier and sourcing structures (where disclosed)

✔ No technical disclosure is initiated without formal confidentiality protection.

• Full Formulation Ownership Transfer

All custom-developed formulations are exclusively owned by the client upon project completion:

• Full transfer of formulation IP rights and technical documentation
• No internal reuse of client-specific formulas
• Complete handover of specifications, SOPs, and COA references
• Batch history and manufacturing records included

✔ Clients retain 100% ownership of developed product formulations.

• Optional Exclusivity Agreement

Exclusivity structures can be customized based on commercial requirements:

• Regional exclusivity (country/territory-based protection)
• Category exclusivity (e.g., liposomal glutathione formulations)
• Time-bound exclusivity periods
• Volume-based exclusivity thresholds

✔ Exclusivity is fully flexible and contract-defined.

• Strict OEM-Only Manufacturing Policy

We operate under a strict OEM/ODM separation model:

• No commercialization of client formulations under any internal brand
• No cross-client reuse of private formulations
• Segregated project data management system per client
• Independent formulation tracking and documentation architecture

✔ Ensures zero conflict of interest and full client trust protection.

13. AFTER-SALES SUPPORT（Technical Lifecycle Support & Issue Resolution System）

✔ This section defines our post-production technical support framework to ensure rapid response, structured issue resolution, and long-term product lifecycle stability for liposomal antioxidant systems.

• 24-Hour Technical Response System

A dedicated technical team provides response within 24 hours for:

• Product performance or stability inquiries
• Manufacturing or batch-related technical questions
• Initial evaluation of quality deviation reports
• Packaging–formulation compatibility questions

✔ Ensures immediate technical acknowledgment and support initiation.

• 72-Hour Root Cause Analysis (RCA) Protocol

In case of quality or performance deviation:

• Structured root cause investigation initiated within 72 hours
• Cross-functional review (QA / QC / production / formulation teams)
• Preliminary technical diagnosis report issued
• Initial corrective action plan proposed

✔ Enables fast diagnosis and controlled issue containment.

• Quality Issue Replacement & CAPA System

For confirmed manufacturing-related issues:

• Batch replacement or compensation based on RCA outcome
• Structured deviation classification (critical / major / minor)
• Corrective and Preventive Action (CAPA) implementation system
• Continuous process improvement integration

✔ Ensures accountability and manufacturing reliability.

• Stability & Performance Investigation Support

For post-market stability concerns:

• Re-evaluation of liposomal integrity under reported conditions
• Packaging–active interaction analysis
• Oxidation pathway and degradation profiling (GSH stability review)
• Shelf-life reassessment where necessary

✔ Supports long-term product performance reliability.

• Regulatory Update Advisory Service

Ongoing compliance monitoring includes:

• Ingredient regulatory status updates (FDA / EFSA / Health Canada / TGA)
• Liposomal delivery system regulatory classification updates
• Labeling requirement adjustments across regions
• Health claim compliance updates for antioxidant positioning

✔ Ensures continuous regulatory alignment for globally marketed products.